[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343282-105":59,"doc-detail-343282-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hyperactivation-of-mtoreif4e-signaling-pathway-promotes-the-production-of-tryptophan-to-phenylalanine-substitutants-in-ebv-positive-gastric-cancer","Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer","","Chronic interferon-β (IFN-β) exposure can induce tryptophan depletion through the indoleamine-2,3-dioxygenase (IDO)-kynurenine pathway, promoting aberrant peptide generation by ribosomal frameshifting and W→F codon reassignment. The study examines how tryptophan shortage influences aberrant peptide production in gastric cancer and finds that EBV-positive tumors receive continuous IFN-β from infiltrating lymphocytes, upregulating IDO1 and triggering W→F substitutant formation. W→F substitutants enhance antigen presentation via mTOR/eIF4E hyperactivation; inhibition of mTOR/eIF4E or EIF4E blocks production and immune activation, suggesting therapeutic vulnerability.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hyperactivation-of-mtoreif4e-signaling-pathway-promotes-the-production-of-tryptophan-to-phenylalanine-substitutants-in-ebv-positive-gastric-cancer/343282/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hyperactivation-of-mtoreif4e-signaling-pathway-promotes-the-production-of-tryptophan-to-phenylalanine-substitutants-in-ebv-positive-gastric-cancer/343282.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does IFN-β contribute to tryptophan shortage in EBV-positive gastric cancer?","Question",{"text":112,"@type":113},"Abundant infiltrating lymphocytes secrete IFN-β, which upregulates IDO1 expression and drives tryptophan depletion via the kynurenine pathway.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are W→F substitutants and how are they generated?",{"text":117,"@type":113},"W→F substitutants are aberrant peptides formed when translation events involving ribosomal frameshifting and tryptophan-to-phenylalanine codon reassignment occur specifically under tryptophan shortage at Trp codons.",{"name":119,"@type":110,"acceptedAnswer":120},"How does mTOR/eIF4E signaling affect antigen presentation in this context?",{"text":121,"@type":113},"mTOR/eIF4E hyperactivation links W→F substitutant production to antigen presentation; blocking the mTOR/eIF4E pathway or reducing EIF4E counteracts both substitutant production and antigen presentation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343282,1790815139,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nHyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer  \nZi-Qi Zheng, Cheng-Rui Zhong, Cheng-Zhi Wei, Xiao-Jiang Chen, Guo-Ming Chen, Run-Cong Nie, Ze-Wei Chen, Fei-Yang Zhang, Yuan-Fang Li, Zhi-Wei Zhou,* Yong-Ming Chen,* and Ye-Lin Liang*  \nAlthough messenger RNA translation is tightly regulated to preserve protein synthesis and cellular homeostasis, chronic exposure to interferon-􀀂 (IFN-􀀂) in several cancers can lead to tryptophan (Trp) shortage via the indoleamine-2,3-dioxygenase (IDO) -kynurenine pathway and therefore promotes the production of aberrant peptides by ribosomal frameshifting and tryptophan-to-phenylalanine (W>F) codon reassignment events (substitutants) speciﬁcally at Trp codons. However, the eﬀect ofTrp depletion on the generation of aberrant peptides by ribosomal mistranslation in gastric cancer (GC) is still obscure. Here, it is shows that the abundant inﬁltrating lymphocytes in EBV-positive GC continuously secreted IFN-􀀂, upregulated IDO1 expression, leading to Trp shortage and the induction ofW>F substitutants. Intriguingly, the production ofW>F substitutants in  \nEBV-positive GC is linked to antigen presentation and the activation of themTOR/eIF4E signaling pathway. Inhibiting either the mTOR/eIF4E pathway or EIF4E expression counteracted the production and antigen presentation of W>F substitutants. Thus, the mTOR/eIF4E pathway exposed the vulnerability of gastric cancer by accelerating the production of aberrant peptides and boosting immune activation through W>F substitutant events. This work proposes that EBV-positive GC patients with mTOR/eIF4E hyperactivation may beneﬁt from anti-tumor immunotherapy.  \n1. Introduction  \nGastric cancer (GC) is a type of malignant tumor derived from the stomach mucous epithelium, with higher mortality and morbidity rates among all cancers worldwide. Most patients with GC are diagnosed at an advanced stage, with a dismal 5-year overall survival rate of about 30% . [1] In recent years, the immunotherapy represented by immune checkpoint inhibitors (ICI) has brought signiﬁcant clinical breakthroughs in GC. [2,3] However, only a small subset of GC patients is sensitive to, and beneﬁt from, the immunotherapy, and the prognosis of GC patients remains unfavorable. [4] Therefore, thereis an urgent need to identify the characteristics of the immune microenvironment and uncover the mechanisms of immunotherapy resistance in gastric cancer.  \nAccording to the Cancer Genome Atlas (TCGA) network, gastric cancer has been identiﬁed into four distinct subtypes by genetic alterations, including microsatelliteunstable/instability (MSI), genomically stable, chromosomal instability and  \nZ.-Q. Zheng, C.-Z. Wei, X.-J. Chen, G.-M. Chen, R.-C. Nie, Z.-W. Chen, F.-Y. Zhang, Y.-F. Li, Z.-W. Zhou, Y.-M. Chen  \nDepartment of Gastric Surgery  \nState Key Laboratory of Oncology in South China Guangdong Provincial Clinical Research Center for Cancer Sun Yat-sen University Cancer Center  \nGuangzhou 510060, P. R. China  \nE-mail: [zhouzhw@sysucc.org.cn](zhouzhw@sysucc.org.cn); [chenyongm@sysucc.org.cn](chenyongm@sysucc.org.cn)  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202402284](https://doi.org/10.1002/advs.202402284)[ ](https://doi.org/10.1002/advs.202402284)© 2024 The Author(s). Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202402284  \nC.-R. Zhong  \nDepartment of General Surgery Hepatobiliary Pancreatic and Splenic Surgery The Sixth Aﬃliated Hospital  \nSun Yat-sen University Guangzhou 510655, P. R. China Y.-L. Liang  \nDepartment of Radiology ","cbCaiu1NSdayfqUD","https://ap.wps.com/l/cbCaiu1NSdayfqUD","pdf",5668512,16,"English","# Introduction\n## Gastric cancer and immunotherapy challenge\n## EBV-positive gastric cancer immune features\n## IFN-β, IDO1, and tryptophan depletion\n## Ribosomal frameshifting and codon reassignment\n# Conclusions","[{\"question\":\"How does IFN-β contribute to tryptophan shortage in EBV-positive gastric cancer?\",\"answer\":\"Abundant infiltrating lymphocytes secrete IFN-β, which upregulates IDO1 expression and drives tryptophan depletion via the kynurenine pathway.\"},{\"question\":\"What are W→F substitutants and how are they generated?\",\"answer\":\"W→F substitutants are aberrant peptides formed when translation events involving ribosomal frameshifting and tryptophan-to-phenylalanine codon reassignment occur specifically under tryptophan shortage at Trp codons.\"},{\"question\":\"How does mTOR/eIF4E signaling affect antigen presentation in this context?\",\"answer\":\"mTOR/eIF4E hyperactivation links W→F substitutant production to antigen presentation; blocking the mTOR/eIF4E pathway or reducing EIF4E counteracts both substitutant production and antigen presentation.\"}]","Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer | PDF",1790050594,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db35f36b11efdf5c02fdbed897fc021a.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32c0dbca119cd30e04b312c49ec09098.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7fc4467f40ecd2744465d475887742d.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b15d4686ea14a8f4aae43edfc72587e.webp",980,1287]